Heart Test Laboratories Inc (HSCS) Stock Price, Quote & News

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices

Sector: Healthcare

Phone: 682 237 7781

Website: heartsciences.com

Address:

550 Reserve Street, Suite 360, Southlake, United States

Atlasquantlabs Jul. 2 at 1:25 AM

$KUST overall it’s still a uptrend with strong pull back to the bottom trendline line! We just need one more strong run up and it should get us to the 3 zone! $SKYQ same thing super strong pull backs then it went back up $HSCS same thing, buy the dips and sell the rips.

0 · Reply

MarketsParadise Jul. 1 at 5:42 PM

Small caps heating up, We are seeing some big runners lately. Take a look at ticker DRCT 💎 I believe this is the next monster runner waiting to be found: DRCT 💎 • 600K share float! • AI-powered digital advertising & marketing drive. • Extremely thin chart. • Any sustained buying pressure we look for the 5$+. $HSCS $GDHG $ZBIO . $CDTG /

0 · Reply

focafoca99 Jun. 26 at 9:38 PM

$HSCS updates on its merger with Fortitude Mining, board expansion and appointment of Andrea Childs as new CEO.

0 · Reply

DrTampa Jun. 26 at 7:36 PM

$HSCS quite the spread between the bid and ask

0 · Reply

BigBoyTroy Jun. 26 at 2:51 PM

$HURA $HSCS always in early time stamped Free discord link in my stoctwits Profile my bullish 🐂 peeps if you are interested in joining

0 · Reply

SqueezeRib Jun. 26 at 2:10 PM

$HSCS

0 · Reply

DrTampa Jun. 26 at 12:46 PM

$HSCS crazy how they're having been any FTDs since May 8th. The suspicious as hell.

1 · Reply

DrTampa Jun. 26 at 12:37 PM

$HSCS webull is showing 248% cost to borrow 👀👀

0 · Reply

DrTampa Jun. 26 at 12:16 PM

$HSCS when shorty being mean to you on stocktwits, this is why...don't sell shorty your shares too cheap, micro cap 3,180,000 float. 184,000,000 shares somehow traded the other day. No current ATM.

0 · Reply

DrTampa Jun. 26 at 11:24 AM

$HSCS Don't let the shorts sell you short, the cost to borrow rate is 230% currently. Fintel isn't showing the rate past June 23 before the pop.

0 · Reply

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 8 days ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 8 days ago

HeartSciences Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 9 days ago

HeartSciences Proxy statement: Proxy filing

Jun 24, 2026, 8:00 AM EDT - 10 days ago

HeartSciences Proxy statement: Proxy filing

2026-06-23T14:26:04.000Z - 11 days ago

HeartSciences, Fortitude announces business combination

Jun 23, 2026, 8:00 AM EDT - 11 days ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 8:00 AM EDT - 11 days ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 7:30 AM EDT - 11 days ago

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

Jun 23, 2026, 7:00 AM EDT - 11 days ago

HeartSciences Slides: Investor presentation

2026-06-11T13:48:30.000Z - 23 days ago

HeartSciences granted European patent for heart-monitoring technology

Jun 11, 2026, 8:30 AM EDT - 23 days ago

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents

Jun 2, 2026, 8:30 AM EDT - 4 weeks ago

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

2026-05-19T12:51:09.000Z - 6 weeks ago

HeartSciences enters commercial agreement with North Shore Health

May 19, 2026, 8:30 AM EDT - 6 weeks ago

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

2026-05-05T13:47:14.000Z - 2 months ago

HeartSciences signs MyoVista commercial agreement with St. Vincent Health

May 5, 2026, 9:00 AM EDT - 2 months ago

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

Apr 14, 2026, 4:15 PM EDT - 2 months ago

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Mar 25, 2026, 8:30 AM EDT - 3 months ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 24, 2026, 11:18 AM EDT - 3 months ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 19, 2026, 8:00 AM EDT - 3 months ago

HeartSciences Proxy statement: Proxy filing

Mar 17, 2026, 8:00 AM EDT - 3 months ago

HeartSciences Proxy statement: Proxy filing

Mar 16, 2026, 4:15 PM EDT - 3 months ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 8:00 AM EDT - 3 months ago

HeartSciences Quarterly report: Q3 2026

Mar 16, 2026, 8:00 AM EDT - 3 months ago

HeartSciences Earnings release: Q3 2026

Mar 6, 2026, 7:00 AM EST - 4 months ago

HeartSciences Proxy statement: Proxy filing

2026-02-05T13:47:11.000Z - 5 months ago

HeartSciences announces UWE adopted MyoVista Insights, MyoVista wavECG

Feb 5, 2026, 8:30 AM EST - 5 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

2026-01-29T13:41:04.000Z - 5 months ago

HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks

Jan 29, 2026, 8:30 AM EST - 5 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Dec 15, 2025, 4:15 PM EST - 7 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

2025-12-15T13:35:23.000Z - 7 months ago

HeartSciences announces FDA 510(k) submission for MyoVista wavECG

Dec 15, 2025, 8:30 AM EST - 7 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 7:00 AM EST - 7 months ago

HeartSciences Quarterly report: Q2 2026

Dec 15, 2025, 7:00 AM EST - 7 months ago

HeartSciences Earnings release: Q2 2026

2025-12-11T13:46:02.000Z - 7 months ago

HeartSciences announces commercial release of MyoVista Insights version 1.1

Dec 11, 2025, 8:30 AM EST - 7 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Sep 12, 2025, 7:00 AM EDT - 10 months ago

HeartSciences Slides: Investor presentation

Sep 11, 2025, 4:15 PM EDT - 10 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 8:00 AM EDT - 10 months ago

HeartSciences Quarterly report: Q1 2026

Sep 11, 2025, 8:00 AM EDT - 10 months ago

HeartSciences Earnings release: Q1 2026

Aug 15, 2025, 9:00 AM EDT - 11 months ago

HeartSciences Announces Conference Participation and Investor Webinar

Jul 24, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Annual report: Q4 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q4 2025

2025-06-04T13:06:22.000Z - 1 year ago

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

Jun 4, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

2025-06-03T13:05:37.000Z - 1 year ago

HeartSciences announces grant by USPTO for ECG assessment of heart function

Jun 3, 2025, 9:00 AM EDT - 1 year ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

2025-05-29T13:05:18.000Z - 1 year ago

HeartSciences signs first MyoVista Insights platform customer

May 29, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 20, 2025, 9:00 AM EDT - 1 year ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

2025-05-07T13:06:44.000Z - 1 year ago

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

2025-05-01T13:28:48.000Z - 1 year ago

HeartSciences launches MyoVista Insights platform

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Quarterly report: Q3 2025

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q3 2025

2025-03-10T13:10:33.000Z - 1 year ago

HeartSciences engages Integrous Communications to enhance communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Quarterly report: Q2 2025

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Earnings release: Q2 2025

2024-11-13T14:12:03.000Z - 1 year ago

Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 27, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Registration statement: Registration filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Proxy statement: Proxy filing

Sep 18, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Proxy statement: Proxy filing

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Quarterly report: Q1 2025

Sep 12, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q1 2025

Jul 29, 2024, 4:05 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Annual report: Q4 2024

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q4 2024

Jul 26, 2024, 9:00 AM EDT - 2 years ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 25, 2024, 8:30 AM EDT - 2 years ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 11, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Quarterly report: Q3 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q3 2024

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 5, 2024, 7:00 AM EST - 2 years ago

HeartSciences Registration statement: Registration filing

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Jan 18, 2024, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 14, 2023, 7:00 AM EST - 2 years ago

HeartSciences Quarterly report: Q2 2024

Dec 14, 2023, 7:00 AM EST - 2 years ago

HeartSciences Earnings release: Q2 2024

Dec 13, 2023, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Dec 8, 2023, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Atlasquantlabs Jul. 2 at 1:25 AM

0 · Reply

MarketsParadise Jul. 1 at 5:42 PM

0 · Reply

focafoca99 Jun. 26 at 9:38 PM

$HSCS updates on its merger with Fortitude Mining, board expansion and appointment of Andrea Childs as new CEO.

0 · Reply

DrTampa Jun. 26 at 7:36 PM

$HSCS quite the spread between the bid and ask

0 · Reply

BigBoyTroy Jun. 26 at 2:51 PM

$HURA $HSCS always in early time stamped Free discord link in my stoctwits Profile my bullish 🐂 peeps if you are interested in joining

0 · Reply

SqueezeRib Jun. 26 at 2:10 PM

$HSCS

0 · Reply

DrTampa Jun. 26 at 12:46 PM

$HSCS crazy how they're having been any FTDs since May 8th. The suspicious as hell.

1 · Reply

DrTampa Jun. 26 at 12:37 PM

$HSCS webull is showing 248% cost to borrow 👀👀

0 · Reply

DrTampa Jun. 26 at 12:16 PM

$HSCS when shorty being mean to you on stocktwits, this is why...don't sell shorty your shares too cheap, micro cap 3,180,000 float. 184,000,000 shares somehow traded the other day. No current ATM.

0 · Reply

DrTampa Jun. 26 at 11:24 AM

$HSCS Don't let the shorts sell you short, the cost to borrow rate is 230% currently. Fintel isn't showing the rate past June 23 before the pop.

0 · Reply

DrTampa Jun. 26 at 1:16 AM

$HSCS 👀👀

0 · Reply

topstockalerts Jun. 25 at 8:11 PM

$HSCS buyers seem to be in no rush to let this go.

0 · Reply

Moneyybaggs Jun. 25 at 7:06 PM

$HSCS Incredible moron!!! Climb back down into your hole!!! BLOCKED!!!

2 · Reply

nerowinger Jun. 25 at 6:33 PM

$HSCS look at his profile classic hscs paidpumper

1 · Reply

nerowinger Jun. 25 at 6:27 PM

$HSCS lol only 5% becomes hscs holder from deal merger..

0 · Reply

Moneyybaggs Jun. 25 at 5:35 PM

$HSCS She’s about to blow!!!!

0 · Reply

DrTampa Jun. 25 at 4:16 PM

$HSCS still no shares available to borrow 👀👀

0 · Reply

DrTampa Jun. 25 at 4:14 PM

$HSCS Yes, I really do own just under 5% of the company, here's a screenshot from one of my portfolios with the majority of the shares. I also have 394,000 of the $5 warrants 🤑🤑

0 · Reply

DrTampa Jun. 25 at 4:02 PM

$HSCS Webull showing a cost to borrow rate of 327% 👀👀

0 · Reply

Igrisu Jun. 25 at 3:40 PM

$HSCS In 2.54 Target 5.34 Lets get it

0 · Reply

Moneyybaggs Jun. 25 at 3:21 PM

$HSCS And then went right back up. Gotta luv that MM fookery!!!

0 · Reply

6Ghost Jun. 25 at 2:49 PM

$HSCS Knocked out everyone's stop losses, damn

0 · Reply

Market Cap	2.27M
Revenue (ttm)	20,000.00
Net Income (ttm)	-6.61M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	11,938
Avg Vol	455,542
Day's Range	N/A - N/A
Shares Out	656,000.00
Stochastic %K	24%
Beta	3.16
Analysts	Strong Sell
Price Target	$13.50